학술논문
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
Document Type
Article
Author
Sacco, Joseph J.; Jackson, Richard; Corrie, Pippa; Danson, Sarah; Evans, T.R. Jeffry; Ochsenreither, Sebastian; Kumar, Satish; Goodman, Andrew; Larkin, James; Karydis, Ioannis; Steven, Neil; Lorigan, Paul; Plummer, Ruth; Patel, Poulam; Psarelli, Eftychia; Olsson-Brown, Anna; Shaw, Heather; Leyvraz, Serge; Handley, Louise; Rawcliffe, Charlotte; Nathan, Paul
Source
In European Journal of Cancer May 2024 202
Subject
Language
ISSN
0959-8049